Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918461 · ClinicalTrials.gov registry record · NA
Emerging From the Haze for Gynecologic Cancer Survivors
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02918461 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT02918461, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks. The objective of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score.
Interventions
- BEHAVIORAL Emerging from the Haze class
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-01-10 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918461
The ClinicalTrials.gov registry entry for NCT02918461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Emerging from the Haze class is the first listed.
NCT02918461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918461 about?
NCT02918461 is a clinical study titled "Emerging From the Haze for Gynecologic Cancer Survivors". At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week...
What is the current status of trial NCT02918461?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2017-01-10. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02918461?
The interventions under investigation include: Emerging from the Haze class (BEHAVIORAL).
Who is sponsoring clinical trial NCT02918461?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.